Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $297.67 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $162.85 | 10 | $0 (2024) |
| Amgen Inc. | $81.00 | 3 | $0 (2019) |
| AstraZeneca UK Limited | $38.07 | 1 | $0 (2019) |
| BIOTRONIK INC. | $15.75 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $70.12 | 4 | Abbott Laboratories ($70.12) |
| 2023 | $50.07 | 3 | Abbott Laboratories ($50.07) |
| 2022 | $16.67 | 1 | Abbott Laboratories ($16.67) |
| 2019 | $91.06 | 4 | AstraZeneca UK Limited ($38.07) |
| 2018 | $69.75 | 3 | Amgen Inc. ($54.00) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: Diabetes Care | ||||||
| 10/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Diabetes Care | ||||||
| 03/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Diabetes Care | ||||||
| 03/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Diabetes Care | ||||||
| 12/22/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Diabetes Care | ||||||
| 11/10/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Diabetes Care | ||||||
| 05/29/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Diabetes Care | ||||||
| 12/15/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Diabetes Care | ||||||
| 07/31/2019 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Diabetes Care | ||||||
| 04/27/2019 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: Diabetes Care | ||||||
| 03/17/2019 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $27.00 | General |
| 03/16/2019 | AstraZeneca UK Limited | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $38.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/11/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: Cardiology | ||||||
| 11/11/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: Cardiology | ||||||
| 08/09/2018 | BIOTRONIK INC. | — | Food and Beverage | In-kind items and services | $15.75 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 9 | 372 | 562 | $88,631 | $27,419 |
| 2020 | 11 | 901 | 1,286 | $193,402 | $58,104 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 24 | 104 | $25,480 | $8,980 | 35.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 47 | 80 | $15,920 | $6,720 | 42.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 22 | 25 | $10,500 | $3,985 | 38.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 19 | 60 | $9,600 | $3,504 | 36.5% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 38 | 38 | $11,590 | $2,153 | 18.6% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 158 | 188 | $9,776 | $1,283 | 13.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 36 | 39 | $3,315 | $369.17 | 11.1% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2021 | 14 | 14 | $1,330 | $255.08 | 19.2% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2021 | 14 | 14 | $1,120 | $169.40 | 15.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 62 | 165 | $40,425 | $14,435 | 35.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 67 | 74 | $31,080 | $12,553 | 40.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 60 | 108 | $21,520 | $8,047 | 37.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 49 | 129 | $20,640 | $7,853 | 38.0% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2020 | 103 | 107 | $32,635 | $6,455 | 19.8% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 437 | 571 | $29,692 | $3,877 | 13.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 20 | 21 | $6,405 | $2,449 | 38.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 26 | 28 | $3,860 | $1,324 | 34.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 41 | 47 | $3,995 | $584.01 | 14.6% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2020 | 18 | 18 | $1,710 | $317.20 | 18.5% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2020 | 18 | 18 | $1,440 | $210.76 | 14.6% |
About Dr. Vijay Kumar, MD
Dr. Vijay Kumar, MD is a Interventional Cardiology healthcare provider based in Bloomingdale, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144244146.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vijay Kumar, MD has received a total of $297.67 in payments from pharmaceutical and medical device companies, with $70.12 received in 2024. These payments were reported across 15 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($297.67).
As a Medicare-enrolled provider, Kumar has provided services to 1,273 Medicare beneficiaries, totaling 1,848 services with total Medicare billing of $85,523. Data is available for 2 years (2020–2021), covering 20 distinct procedure/service records.
Practice Information
- Specialty Interventional Cardiology
- Location Bloomingdale, IL
- Active Since 07/26/2006
- Last Updated 11/17/2014
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1144244146
Products in Payments
- FREESTYLE LIBRE 2 (Device) $97.97
- Repatha (Biological) $54.00
- FREESTYLE LIBRE 3 (Device) $38.89
- LOKELMA (Drug) $38.07
- FreeStyle Libre (Device) $25.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.